Television Q&A: Why do shows in syndication air out of order?

Published by
Tribune News Service

You have questions. I have some answers. Q: Many times, when I’m watching reruns of a particular series, they’ll show several episodes in a row. However, most of the time those episodes are not chronological. For example, Season 1, Episode 4 may be followed by a Season 3, Episode 6. Why aren’t they shown in their original broadcast sequence? A: When I am wasting time — I mean, doing research — by watching reruns on some cable channels in the daytime, I will often see episodes run in chronological order, especially when the storyline is a multi-episode one. But that depends on the network and t… Continue reading “Television Q&A: Why do shows in syndication air out of order?”

22 Trends That Will Define the Lives of American Men in 2022

Published by
InsideHook

By The Editors We first published this feature back in 2014. It was one of those native-content jobbies. For Cadillac, I believe. Our assignment was to make a bunch of predictions about how American men’s lives would change over the year ahead, and one of those predictions must have involved buying a big bad American car. The whole thing was captained by my old boss Steve Bryant, a very wise man to whom this website remains indebted to this day. I remember watching him furrow his brow and stare at his screen with great intensity as he tried to summon the Nostradamus from within himself. It’s a… Continue reading “22 Trends That Will Define the Lives of American Men in 2022”

Nets Face Unprecedented Path With Kyrie Irving’s Return

Published by
Sports Illustrated

By Howard Beck For all the feel-good snapshots Wednesday in Irving’s return—Brooklyn’s path from here is indisputably strange and potentially rocky with his decision to remain unvaccinated. View the original article to see embedded media. Kyrie Irving was back on NBA hardwood Wednesday night, performing familiar feats of basketball sorcery, and it was frankly a joy to behold. Anyone who loves the game had to delight in seeing Kyrie do Kyrie things again—the mesmerizing footwork, the bullet passes, the breezy jumpers—in his extremely belated debut for the Nets. You don’t have to be a Nets loyal… Continue reading “Nets Face Unprecedented Path With Kyrie Irving’s Return”

Hisense Plans to Bring More High Performing and High-quality Display Products to African Market in 2022

JOHANNESBURG, South Africa, Jan. 6, 2022 /PRNewswire/ — Hisense, provider of high-performance televisions and appliances, showcased its 8K resolution laser display technology solution and ULED 8K Mini-LED series at the recent Consumer Electronics Show 2022 (“CES 2022”) held in Las Vegas. Following the introduction of the world’s first 8K laser display for homes at the most influential tech event in the world, Hisense will introduce two more high-end products to the African market this January, with more high performing products coming later in 2022.

Hisense Plans to Bring More High Performing and High-quality Display Products to African Market in 2022

“Through continuous technological innovation, Hisense is breaking through technical barriers bringing laser TVs from 1080P to 2K to 4K and now on to 8K, driving the global laser TV industry into the TriChroma era. We are committed to bringing trustworthy products to millions of our users in Africa through outstanding design, leading technology and excellent service,” said Patrick Hu, marketing director of Hisense South Africa.

Featuring Hisense’s TriChroma laser engine that reaches up to 3000 lumens peak brightness, the L9G TriChroma Laser TV will be available in the region of Africa this January. It is a 4K ultra short throw projection TV with a triple-laser, using pure red, green, and blue lasers to achieve new levels of color performance. It has won the “King of Ultra Short Throw Projectors” and named Best in Class by Projector Reviews and awarded Editor’s Choice by Projector Central in 2021.

In addition to the L9G, Hisense will also launch the 4K Mini-LED U9G TV in the African market this month. In June 2022, the new 4K Mini-LED U8H TV will bring even more premium upgrades and quality performance to consumers in the region. With screen sizes ranging from 55 to 75-inches, the 120Hz native refresh rate of the U8H provides a foundation for smooth clarity and motion handling, making action movies and sports look great on the screen.

In 2022, Hisense is implementing its Mini LED technology into its new premium 8K Mini-LED TV product for the first time, delivering stunning HDR performance with better contrast, brighter images, and more impressive colors than ever before. Hisense 8K Mini LED TV won CES® 2022 Innovation Award, and this advanced technology will also be brought to the African market. The flagship U80H 8K Mini LED TV is set to be launched in the African market in July 2022.

Photo – https://mma.prnewswire.com/media/1721327/Hisense.jpg

 

Zenas BioPharma Appoints Dr. John Orloff to Board of Directors

BOSTON and SHANGHAI, China, Jan. 06, 2022 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and delivery of immune-based therapies, today announced the appointment of John Orloff, MD to its Board of Directors. Dr. Orloff joins the Zenas Board with over 25 years of experience successfully leading global research and development organizations across multiple therapeutic areas including autoimmune diseases.

“We are extremely pleased to welcome Dr. Orloff to the Zenas Board of Directors,” said Lonnie Moulder, Founder and Executive Chairman of Zenas. “John’s leadership and extensive expertise in research, development, and medical and regulatory affairs will be invaluable as we advance our portfolio of innovative immune-based therapeutics and continue to expand our pipeline via business development.”

“I am delighted to work with the Zenas leadership team and fellow directors as the Company rapidly progresses an exciting immune-based pipeline,” said Dr. Orloff. “I look forward to contributing to the Company’s continued development as it strives to deliver on its mission to bring innovative medicines to patients in need.”

Dr. Orloff currently serves as a venture partner with Agent Capital. In his most recent executive role, he served as Executive Vice President and Head of Research and Development at Alexion where his leadership in expanding the development pipeline to 30 programs supported the recent $39 billion acquisition of Alexion by AstraZeneca.

Prior to Alexion, Dr. Orloff served as Global Head of R&D and Chief Scientific Officer at Baxalta, and has also held executive leadership roles with Novelion, Baxter International, Merck Serono, Novartis and Merck Research Laboratories. Before entering the biopharmaceutical industry, he was a faculty member of the Yale University School of Medicine. Dr. Orloff received an undergraduate degree in chemistry from Dartmouth College, earned his medical degree from the University of Vermont, College of Medicine and completed a fellowship in endocrinology and metabolism at Yale University School of Medicine.

About Zenas BioPharma

Zenas BioPharma is a global biopharmaceutical company based in the USA and China committed to becoming a leader in the development and delivery of immune-based therapies for patients in the US, China and around the world. Zenas is rapidly advancing a deep pipeline of innovative therapeutics that continues to grow through our successful business development strategy. Our experienced leadership team and network of business partners drive operational excellence to deliver potentially transformative therapies to improve the lives of those facing autoimmune and rare diseases. For more information about Zenas BioPharma, please visit www.zenasbio.com and follow us on Twitter at @ZenasBioPharma and LinkedIn.

Investor and Media Contact:
Joe Farmer
Zenas BioPharma
IR@zenasbio.com

Harris fait l’acqusition du portefeuille de produits i2 d’IBM

OTTAWA, Ontario, et CAMBRIDGE, Royaume-Uni, 05 janv. 2022 (GLOBE NEWSWIRE) — Harris, un fournisseur mondial de logiciels sur le marché vertical, a fait l’acquisition du portefeuille de produits d’analyse du renseignement i2 d’IBM, y compris les plateformes i2 Analyst’s Notebook, i2 Enterprise Insight Analysis (EIA) et i2 iBase. Cette acquisition permet à Harris de continuer à fournir des applications critiques pour la défense nationale, l’application de la loi par les États et les collectivités locales, la sécurité maritime et la gestion des preuves.

Les outils avancés d’analyse et d’analyse du renseignement d’i2, tels que la plateforme leader du secteur i2 Analyst’s Notebook, aident les analystes à transformer les données en décisions en temps quasi réel, à découvrir des connexions cachées avec des affichages visuels et à transformer des données volumineuses et disparates, quelle que soit la source, en renseignement exploitable.

Le portefeuille de produits i2, les cadres i2 et leurs équipes mondiales formeront une nouvelle unité commerciale Harris, i2 Group, qui fonctionnera de manière indépendante et autonome. Jean Soucy, président du groupe Harris, a déclaré : « L’acquisition d’i2 est importante pour Harris car il s’agit non seulement d’une entreprise éprouvée avec une excellente équipe internationale d’experts, mais elle fournit également à Harris une plateforme de renseignements riche en fonctionnalités largement déployée par une clientèle influente ». Il a ajouté : « Nous sommes impatients de travailler avec nos partenaires et clients pour étendre les capacités d’i2 dans cet espace hautement innovant. »

« La résilience et la collaboration n’ont jamais été aussi cruciales pour les organisations qui font face à la complexité croissante de l’analyse du renseignement. Nous nous engageons à répondre à ces besoins en offrant le portefeuille d’analyses du renseignement de bout en bout le plus complet du marché », a commenté Jamie Caffrey, directeur de programme chez i2 Group. « La convergence des données et des processus transforme l’industrie. En intégrant i2 à leurs réseaux existants, les clients seront en mesure de mieux tirer parti de leurs données et seront habilités à libérer des informations précieuses qui peuvent se traduire par la réussite de l’entreprise. »

En tant que membre de la société cotée en bourse Constellation Software Inc. (TSX : CSU), la solidité financière, l’expertise de l’industrie du logiciel et l’accent mis sur la sécurité publique de Harris ont été des facteurs importants pour trouver un foyer permanent afin d’exécuter les stratégies de croissance à long terme du groupe i2.

Rendez-vous sur www.i2group.com pour en savoir plus sur les solutions i2.

Pour tout complément d’information, veuillez contacter :

Jean Soucy
Président du groupe
Tél. : +1 581-205-9821
E-mail : JSoucy@harriscomputer.com

Steve Hammond
Leader du portefeuille
Tél. : +44 787-486-2811
E-mail : SHammond@harriscomputer.com

À propos de N. Harris Computer Corporation (Harris)

Harris fait l’acquisition d’entreprises de logiciels de marché vertical, les gère scrupuleusement et les construit pour l’avenir. Grâce à ses acquisitions, Harris s’est largement développée depuis ses origines dans les secteurs des services publics, de l’administration locale, de l’éducation et de la santé, afin d’exploiter plus de 170 entreprises dans le monde entier dans plus de 20 secteurs. Nous faisons partie de Constellation Software Inc. (TSX : CSU), l’un des acquéreurs les plus actifs au monde d’entreprises VMS.

À propos de Constellation Software Inc.
Constellation Software fait l’acquisition, gère et construit des entreprises de logiciels du marché vertical.